334
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Platelet function in patients with chronic myeloid leukemia treated with asciminib

ORCID Icon, , , , &
Pages 3021-3023 | Received 19 May 2020, Accepted 30 Jun 2020, Published online: 12 Jul 2020
 

Disclosure statement

GN: The author reports no conflict of interest. ML: Speaker fees from Pfizer. SC: The author reports no conflict of interest. AI: The author reports no conflict of interest. JA: Research funding and honoraria from Pfizer, honoraria from BMS, research funding and honoraria from Ariad (Incyte), honoraria from Novartis, support and senior investigator for Imperial College NIHR Biomedical Research Center. DM: Honoraria from Pfizer, BMS, Ariad (Incyte) and Novartis. Support for Imperial College NIHR Biomedical Research Center.

Author contributions

GN: wrote the manuscript and performed data analysis. DM: designed and supervised the study, and reviewed the manuscript. ML, SC, AI, JA: reviewed the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.